Neoplasms, Colorectal Completed Phase 3 Trials for Irinotecan (DB00762)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01996306A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRCTreatment
NCT00101686Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.Treatment
NCT00143403Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal CancerTreatment
NCT00561470Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenTreatment